Updates

CSRXP AD BLITZ: LAWMAKERS MUST HOLD BIG PHARMA ACCOUNTABLE NOW

Jun 1, 2021

Campaign Calls for Promises Made to the American People to Lower Prescription Read More

CSRXP COMMENDS PRESIDENT BIDEN FOR RENEWING COMMITMENT TO LOWERING PRESCRIPTION DRUG PRICES IN BUDGET

May 28, 2021

Time for the Administration and Congress to Convert Promises Made Into Read More

DOSE OF REALITY: HUMIRA: A CASE STUDY IN BIG PHARMA GREED

May 17, 2021

AbbVie CEO Headed for Capitol Hill to Answer for Indefensible Anti-Competitive Read More

THEY SAID IT! LAWMAKERS CALL FOR BIPARTISAN ACTION TO LOWER RX PRICES IN PAIR OF HOUSE HEARINGS

May 5, 2021

Members of Congress in Both Parties Recognize Urgency for Solutions to Deliver Read More

BIG PHARMA EARNINGS WATCH: PFIZER, ABBVIE & ASTRAZENECA

May 5, 2021

Drug Companies Top Wall Street Expectations; Pfizer Raises Guidance Based On Read More

BIG PHARMA EARNINGS WATCH: SANOFI, MERCK, BRISTOL-MYERS SQUIBB, AMGEN & GLAXOSMITHKLINE

May 4, 2021

Brand Name Drug Makers Boosting Profits, Sales After Engaging In Pandemic Read More

BIG PHARMA WATCH: GAO REPORT FINDS U.S. CONSUMERS PAY DOUBLE TO QUADRUPLE FOR RX DRUGS

Apr 29, 2021

Study Finds Americans Face Much Higher Drug Prices Than Patients In Other Read More

BIG PHARMA EARNINGS WATCH: NOVARTIS, ELI LILLY & ROCHE

Apr 29, 2021

Trio of Big Pharma Firms Bank Q1 Profits Driven By Price Hikes New first Read More

CSRXP APPLAUDS PRESIDENT BIDEN’S CALL FOR BIPARTISAN SOLUTIONS TO LOWER DRUG PRICES

Apr 29, 2021

Administration and Congress Must Work Together To Pass Solutions to Hold Big Read More

CSRXP: TIME FOR POLICYMAKERS TO DELIVER ON AMERICANS’ CALL TO LOWER OUT-OF-CONTROL DRUG PRICES

Apr 28, 2021

Holding Big Pharma Accountable Remains Top Priority for American Voters Read More

CSRXP: HR3 REINTRODUCTION ADDS TO MOMENTUM FOR D.C. TO LOWER DRUG PRICES, HOLD BIG PHARMA ACCOUNTABLE

Apr 22, 2021

Congress and the Administration Must Act on Solutions that Have Won Bipartisan Read More